Partial safety of the new COX-2 inhibitor rofecoxib in NSAIDs high sensitive patients.

Abstract

AllergyVolume 59, Issue 10 p. 1133-1134 Partial safety of the new COX-2 inhibitor rofecoxib in NSAIDs high sensitive patients A. Matucci, A. Matucci Department of Internal Medicine Section of Immunoallergology and Respiratory Diseases University of Florence Policlinico di Careggi Viale Morgagni 85 50134 Florence Italy Tel: +39 055 4296426 Fax: +39 055 412867 E-mail: [email protected]Search for more papers by this authorP. Parronchi, P. Parronchi Department of Internal Medicine Section of Immunoallergology and Respiratory Diseases University of Florence Policlinico di Careggi Viale Morgagni 85 50134 Florence Italy Tel: +39 055 4296426 Fax: +39 055 412867 E-mail: [email protected]Search for more papers by this authorA. Vultaggio, A. Vultaggio Department of Internal Medicine Section of Immunoallergology and Respiratory Diseases University of Florence Policlinico di Careggi Viale Morgagni 85 50134 Florence Italy Tel: +39 055 4296426 Fax: +39 055 412867 E-mail: [email protected]Search for more papers by this authorO. Rossi, O. Rossi Department of Internal Medicine Section of Immunoallergology and Respiratory Diseases University of Florence Policlinico di Careggi Viale Morgagni 85 50134 Florence Italy Tel: +39 055 4296426 Fax: +39 055 412867 E-mail: [email protected]Search for more papers by this authorF. Brugnolo, F. Brugnolo Department of Internal Medicine Section of Immunoallergology and Respiratory Diseases University of Florence Policlinico di Careggi Viale Morgagni 85 50134 Florence Italy Tel: +39 055 4296426 Fax: +39 055 412867 E-mail: [email protected]Search for more papers by this authorE. Maggi, E. Maggi Department of Internal Medicine Section of Immunoallergology and Respiratory Diseases University of Florence Policlinico di Careggi Viale Morgagni 85 50134 Florence Italy Tel: +39 055 4296426 Fax: +39 055 412867 E-mail: [email protected]Search for more papers by this authorS. Romagnani, S. Romagnani Department of Internal Medicine Section of Immunoallergology and Respiratory Diseases University of Florence Policlinico di Careggi Viale Morgagni 85 50134 Florence Italy Tel: +39 055 4296426 Fax: +39 055 412867 E-mail: [email protected]Search for more papers by this author A. Matucci, A. Matucci Department of Internal Medicine Section of Immunoallergology and Respiratory Diseases University of Florence Policlinico di Careggi Viale Morgagni 85 50134 Florence Italy Tel: +39 055 4296426 Fax: +39 055 412867 E-mail: [email protected]Search for more papers by this authorP. Parronchi, P. Parronchi Department of Internal Medicine Section of Immunoallergology and Respiratory Diseases University of Florence Policlinico di Careggi Viale Morgagni 85 50134 Florence Italy Tel: +39 055 4296426 Fax: +39 055 412867 E-mail: [email protected]Search for more papers by this authorA. Vultaggio, A. Vultaggio Department of Internal Medicine Section of Immunoallergology and Respiratory Diseases University of Florence Policlinico di Careggi Viale Morgagni 85 50134 Florence Italy Tel: +39 055 4296426 Fax: +39 055 412867 E-mail: [email protected]Search for more papers by this authorO. Rossi, O. Rossi Department of Internal Medicine Section of Immunoallergology and Respiratory Diseases University of Florence Policlinico di Careggi Viale Morgagni 85 50134 Florence Italy Tel: +39 055 4296426 Fax: +39 055 412867 E-mail: [email protected]Search for more papers by this authorF. Brugnolo, F. Brugnolo Department of Internal Medicine Section of Immunoallergology and Respiratory Diseases University of Florence Policlinico di Careggi Viale Morgagni 85 50134 Florence Italy Tel: +39 055 4296426 Fax: +39 055 412867 E-mail: [email protected]Search for more papers by this authorE. Maggi, E. Maggi Department of Internal Medicine Section of Immunoallergology and Respiratory Diseases University of Florence Policlinico di Careggi Viale Morgagni 85 50134 Florence Italy Tel: +39 055 4296426 Fax: +39 055 412867 E-mail: [email protected]Search for more papers by this authorS. Romagnani, S. Romagnani Department of Internal Medicine Section of Immunoallergology and Respiratory Diseases University of Florence Policlinico di Careggi Viale Morgagni 85 50134 Florence Italy Tel: +39 055 4296426 Fax: +39 055 412867 E-mail: [email protected]Search for more papers by this author First published: 07 September 2004 https://doi.org/10.1111/j.1398-9995.2004.00532.xCitations: 14 COX-2 inhibitor is relatively safe in patients with a high degree of NSAIDs hypersensitivity. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume59, Issue10October 2004Pages 1133-1134 RelatedInformation